Literature DB >> 6273432

Identification of lysine residues in the binding domain of ribonuclease A for the RNase inhibitor from human placenta.

P Blackburn, J G Gavilanes.   

Abstract

Amidination of the available lysine residues of the complex between RNase A and human placental RNase inhibitor has been performed with methyl acetimidate; the conditions of the derivatization preserve the complex functionally intact. Resistance of epsilon-acetimidyllysine residues to hydrolysis by trypsin allowed, after peptide mapping, the identification of lysine residues 7, 31, 41, 61, and 91 as those which were fully protected by the inhibitor from amidination. Lysine residue 37 was partially protected from amidination. In the presence of poly(A), lysine residues 41 and 61 of RNase A were fully protected from amidination, while lysine residues 7, 31, 37, 91, and 104 were only partially protected; the enzyme retained full activity. The results permit identification of lysine residues located in the binding domain of RNase A for the inhibitor. This region is not identical with, but does overlap, the binding domain for poly(A).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6273432

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

2.  Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

Authors:  J M Fominaya; J M García-Segura; M Ferreras; J G Gavilanes
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

3.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.

Authors:  R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Interaction of semisynthetic variants of RNase A with ribonuclease inhibitor.

Authors:  U Neumann; J Hofsteenge
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.